Found 15 matching trials
RDEA3170 AME Study
PHASE1This study will determine the characteristics of absorption, metabolism, an...
Location
Multiple Locations
Phase 2a RDEA3170 and Allopurinol Combination Study in Gout Subjects
PHASE2This is a Phase 2a, randomized, open-label, multicenter study to assess the...
Location
Multiple Locations
Intensive Uric Acid Lowering With Verinurad and Febuxostat in Patients With Albuminuria
PHASE2The purpose of this clinical research study is to evaluate signals of poten...
RDEA3170 and Febuxostat Drug Interaction Study
PHASE1This study will evaluate the potential pharmacokinetic (PK) and pharmacodyn...
Location
Multiple Locations
Phase II Dose Finding Study of RDEA3170 Versus Placebo in Japanese Patients With Gout or Asymptomatic Hyperuricemia
PHASE2This study is to examine the hypothesis that administration of RDEA3170 to ...
RDEA3170 and Febuxostat Combination Study in Gout Subjects
PHASE2This is a Phase 2a, randomized, open-label, multicenter study to assess the...
Location
Multiple Locations
RDEA3170 Bioavailability Study
PHASE1This is a Phase 1, randomized, open-label, 4-way crossover pharmacokinetic ...
Location
Multiple Locations
RDEA3170 Monotherapy in Subjects With Gout
PHASE2This study will assess the serum uric acid lowering effects and safety of 3...
Location
Multiple Locations
RDEA3170 PK/PD Study
PHASE1The purpose of this study is to examine the pharmacokinetic and pharmacodyn...
Location
Multiple Locations
RDEA3170 and Allopurinol Combination Study in Gout Subjects
PHASE1This is a Phase 1b, randomized, open-label, drug-drug interaction study in ...
Location
Multiple Locations